1. Home
  2. SUNS vs CRDF Comparison

SUNS vs CRDF Comparison

Compare SUNS & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$9.36

Market Cap

129.5M

Sector

Real Estate

ML Signal

HOLD

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$1.96

Market Cap

114.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
CRDF
Founded
2023
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.5M
114.5M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
SUNS
CRDF
Price
$9.36
$1.96
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$12.00
$9.63
AVG Volume (30 Days)
61.4K
989.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
12.70%
N/A
EPS Growth
N/A
27.37
EPS
N/A
N/A
Revenue
N/A
$365,993.00
Revenue This Year
$165.88
N/A
Revenue Next Year
$46.38
N/A
P/E Ratio
$8.84
N/A
Revenue Growth
N/A
49.61
52 Week Low
$7.80
$1.48
52 Week High
$12.19
$4.56

Technical Indicators

Market Signals
Indicator
SUNS
CRDF
Relative Strength Index (RSI) 50.51 51.82
Support Level $9.31 $1.48
Resistance Level $9.65 $2.41
Average True Range (ATR) 0.22 0.11
MACD 0.02 0.08
Stochastic Oscillator 53.52 78.64

Price Performance

Historical Comparison
SUNS
CRDF

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Share on Social Networks: